Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Curr Psychiatry Rep. 2014 Oct;16(10):478. doi: 10.1007/s11920-014-0478-4

TABLE 1.

Double-blind Randomized Placebo-controlled Clinical Trials Measuring the Efficacy of Psychostimulants in Treating Emotional Dysregulation in ADHD

Study (Year) Participants: (N) Design (Duration) Medication (dose)a Outcome Measure Treatment Response
Adults
Reimherr et al. (2007) (47)
Adults w/ primary ADHD
Crossover, placebo- controlled trial (Each arm: 4 weeks) OROS Methylphenidate (0.75 mg/kg) Wender- Reimherr Adult ADHD Scale, emotional dysregulation items OROS
Methylphenidate reduced emotional dysregulation (effect size: 0.7)
Rösler et al. (2010) (363)
Adults w/ primary ADHD
Multi-center, parallel group, placebo- controlled trial (24 weeks) Methylphenidate-ER (0.55 mg/kg) Wender- Reimherr Adult ADHD Scale, emotional dysregulation items Methylphenidate – ER reduced emotional lability (effect size: 0.28– 0.4)
Marchant et al. (2011) (90)
ADHD alone: N=21; ADHD + EDb: N=28; ADHD + ODDc: N=9; ADHD + ED + ODD: N=32
Cross-over, placebo- controlled trial of transdermal MPH (each arm: 4 weeks) Transdermal Methylphenidate Patch (23.8 mg ± 6.6 mg) Wender- Reimherr Adult ADHD Scale, emotional dysregulation items All groups showed benefit on psychostimulants; trend for those with ED to demonstrate greatest improvement
Children
Childress et al. (2011) (283)
6–12 years with primary ADHD; 179 with prominent emotional lability at baseline
Multi-center, parallel group, placebo- controlled trial (4 weeks total) Lisdexamfetamine (LDX) (30, 50, or 70 mg/day) Conners Parent Rating Scale of emotional lability (angry, loss of temper, and irritability) Lisdexamfetamine significantly reduced emotional dysregulation in participants with prominent emotional lability but not in those with low emotional lability
Coghill et al. (2007) (75)
7–15 boys with ADHD (76% with comorbid diagnoses; 41% with ODD & 28% with Conduct Disorder
Cross-over, placebo- controlled trial (12 weeks total) Methylphenidate 0.3 vs. 0.6 mg/kg/dose BID vs. placebo Conners Parent and Teacher Rating Scales of emotional lability Low and high doses of Methylphenidate significantly reduced emotional lability in parent and teacher reports. Low dose (effect-size parent: 0.46; teacher: 0.45). High dose (effect size parent: 0.42; teacher: 0.79)
a

Mean Dosage

b

ED: Emotional dysregulation

c

ODD: Oppositional Defiant Disorder